Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Stock Short Interest Jumps 76.0%

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 97,838 shares, an increase of 76.0% from the September 30th total of 55,588 shares. Based on an average daily trading volume, of 86,848 shares, the days-to-cover ratio is currently 1.1 days. Approximately 0.0% of the company’s shares are sold short.

Sernova Biotherapeutics Trading Down 2.5%

Shares of SEOVF traded down $0.00 during trading hours on Monday, reaching $0.07. 26,000 shares of the company traded hands, compared to its average volume of 57,120. The firm has a market cap of $27.95 million, a price-to-earnings ratio of -1.85 and a beta of 0.90. Sernova Biotherapeutics has a 12-month low of $0.06 and a 12-month high of $0.14. The stock’s fifty day moving average price is $0.08 and its 200 day moving average price is $0.10.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings results on Thursday, September 10th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01).

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body.

Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.